JP2021522344A5 - - Google Patents
Info
- Publication number
- JP2021522344A5 JP2021522344A5 JP2021509954A JP2021509954A JP2021522344A5 JP 2021522344 A5 JP2021522344 A5 JP 2021522344A5 JP 2021509954 A JP2021509954 A JP 2021509954A JP 2021509954 A JP2021509954 A JP 2021509954A JP 2021522344 A5 JP2021522344 A5 JP 2021522344A5
- Authority
- JP
- Japan
- Prior art keywords
- dosage form
- approximately
- magnesium
- disorder
- disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024178890A JP2025011238A (ja) | 2018-04-25 | 2024-10-11 | トレオン酸マグネシウム組成物及びその使用 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862662756P | 2018-04-25 | 2018-04-25 | |
| US62/662,756 | 2018-04-25 | ||
| PCT/US2019/028903 WO2019209943A1 (en) | 2018-04-25 | 2019-04-24 | Magnesium threonate compositions and uses thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024178890A Division JP2025011238A (ja) | 2018-04-25 | 2024-10-11 | トレオン酸マグネシウム組成物及びその使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021522344A JP2021522344A (ja) | 2021-08-30 |
| JP2021522344A5 true JP2021522344A5 (https=) | 2022-04-28 |
Family
ID=68291941
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021509954A Pending JP2021522344A (ja) | 2018-04-25 | 2019-04-24 | トレオン酸マグネシウム組成物及びその使用 |
| JP2024178890A Pending JP2025011238A (ja) | 2018-04-25 | 2024-10-11 | トレオン酸マグネシウム組成物及びその使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024178890A Pending JP2025011238A (ja) | 2018-04-25 | 2024-10-11 | トレオン酸マグネシウム組成物及びその使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US11717501B2 (https=) |
| EP (1) | EP3784227A4 (https=) |
| JP (2) | JP2021522344A (https=) |
| KR (1) | KR20210005662A (https=) |
| CN (3) | CN112384210A (https=) |
| AU (2) | AU2019261406A1 (https=) |
| BR (1) | BR112020021812A2 (https=) |
| CA (1) | CA3098360A1 (https=) |
| WO (1) | WO2019209943A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112384210A (zh) | 2018-04-25 | 2021-02-19 | 纽罗森特里亚股份有限公司 | 苏糖酸镁组合物及其用途 |
| MY197760A (en) | 2020-06-01 | 2023-07-13 | Celagenex Res India Pvt Ltd | Novel synergistic medicinal compositions for treating dysfunctional d-serine signaling |
| JP7805352B2 (ja) * | 2020-08-28 | 2026-01-23 | ディーエフアイ ユーエスエー，エルエルシー | Ｌ－キシロン酸からｌ－トレオン酸塩を生産する方法 |
| CN114304610A (zh) * | 2021-12-24 | 2022-04-12 | 苏州麦轮生物科技有限公司 | 一种含有苏糖酸镁的营养补充剂及其应用 |
| WO2024232931A1 (en) * | 2023-05-11 | 2024-11-14 | Yon Doo Ough | Apparatus and method for contact free delivery and administration of magnesium as a drug |
| CN119504413A (zh) * | 2025-01-20 | 2025-02-25 | 浙江天启生化股份有限公司 | 一种l-苏糖酸镁合成方法及应用 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6010718A (en) * | 1997-04-11 | 2000-01-04 | Abbott Laboratories | Extended release formulations of erythromycin derivatives |
| GB0009522D0 (en) * | 2000-04-19 | 2000-06-07 | Smithkline Beecham Plc | Composition |
| EP1524981B1 (en) * | 2002-07-29 | 2009-03-11 | Glaxo Group Limited | Sustained release formulations comprising lamotrigine |
| CN113143901A (zh) * | 2007-03-22 | 2021-07-23 | 纽罗森特里亚股份有限公司 | 镁组合物及其用途 |
| US8163301B2 (en) | 2007-03-22 | 2012-04-24 | Magceutics, Inc. | Magnesium compositions and uses thereof for metabolic disorders |
| EP2448413A4 (en) | 2009-07-01 | 2013-02-13 | Magceutics Inc | SLOW RELEASE MAGNESIUM COMPOSITION AND USES THEREOF |
| RU2607595C2 (ru) * | 2010-02-03 | 2017-01-10 | Фарма Ту Б Лтд. | Составы разагилина с пролонгированным высвобождением и их применение |
| WO2017044486A1 (en) * | 2015-09-11 | 2017-03-16 | Neurocentria, Inc. | Threonate compounds and methods of use thereof |
| CN105326855A (zh) * | 2015-10-27 | 2016-02-17 | 南京大学 | 易吸收复合夹层式螯合镁钙片 |
| CN105326955B (zh) * | 2015-11-02 | 2019-04-12 | 北京市眼科研究所 | 一种治疗睑缘炎的组合物及其制备方法 |
| US10617713B2 (en) * | 2016-03-08 | 2020-04-14 | Neurocentria, Inc. | Methods of modifying neuronal function by changing intracellular magnesium levels |
| CN107625776A (zh) * | 2016-07-19 | 2018-01-26 | 无锡脑镁素生物医药科技有限公司 | 用于改善睡眠的镁组合物及其用途 |
| CN106360734A (zh) * | 2016-09-28 | 2017-02-01 | 张家港威胜生物医药有限公司 | 一种同时具有减肥和美容作用的组合物及其制备方法与用途 |
| WO2018200885A1 (en) * | 2017-04-26 | 2018-11-01 | Neurocentria, Inc. | Magnesium compositions and methods of use |
| CN112384210A (zh) | 2018-04-25 | 2021-02-19 | 纽罗森特里亚股份有限公司 | 苏糖酸镁组合物及其用途 |
-
2019
- 2019-04-24 CN CN201980042120.9A patent/CN112384210A/zh active Pending
- 2019-04-24 CN CN202510100476.0A patent/CN120241690A/zh active Pending
- 2019-04-24 US US16/393,298 patent/US11717501B2/en active Active
- 2019-04-24 EP EP19792918.5A patent/EP3784227A4/en active Pending
- 2019-04-24 CA CA3098360A patent/CA3098360A1/en active Pending
- 2019-04-24 AU AU2019261406A patent/AU2019261406A1/en not_active Abandoned
- 2019-04-24 JP JP2021509954A patent/JP2021522344A/ja active Pending
- 2019-04-24 CN CN202510100404.6A patent/CN120168449A/zh active Pending
- 2019-04-24 BR BR112020021812-0A patent/BR112020021812A2/pt unknown
- 2019-04-24 WO PCT/US2019/028903 patent/WO2019209943A1/en not_active Ceased
- 2019-04-24 KR KR1020207033637A patent/KR20210005662A/ko active Pending
-
2023
- 2023-06-15 US US18/210,515 patent/US20240156761A1/en active Pending
-
2024
- 2024-10-11 JP JP2024178890A patent/JP2025011238A/ja active Pending
-
2025
- 2025-02-27 AU AU2025201393A patent/AU2025201393A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021522344A5 (https=) | ||
| EP3641742B1 (en) | Hydroxynorketamine for the use in the treatment of depression | |
| TWI335217B (en) | Pharmaceutical formulations of modafinil | |
| JP2012229261A (ja) | 神経刺激性ステロイドの医薬組成物及びその使用 | |
| CN117137912A (zh) | 选择性s1p1受体激动剂的给药方案 | |
| US11654113B2 (en) | Modified release formulations and uses thereof | |
| SG11202112043PA (en) | Combination therapies comprising apremilast and tyk2 inhibitors | |
| KR20150119227A (ko) | 라퀴니모드에 의한 다발성 경화증의 진행형 형태의 치료 | |
| JP2025169294A (ja) | カルバメート化合物を含む経口用医薬組成物及びその製造方法 | |
| AU2018290287A1 (en) | Gastro-resistant controlled release oral dosage forms | |
| US20220323409A1 (en) | Modified release formulations and uses thereof | |
| US10278977B2 (en) | Methods for treating hypersomnolence | |
| JPS63165314A (ja) | 医薬 | |
| JPH0761923A (ja) | アルツハイマー病治療剤 | |
| WO2008025780A1 (en) | Titration schedule for bifeprunox for treating schizophrenia and kits for use therein | |
| US20250388588A1 (en) | Pkc inhibitor solid state forms | |
| TW201540300A (zh) | 慢性腎臟病之進展抑制或改善用製劑 | |
| JP2025083453A (ja) | Ｆｇｆｒ４阻害剤の経口製剤によるがんの治療方法 | |
| JP7399502B2 (ja) | びらん性変形性手関節症の治療のためのモンテルカスト | |
| KR20070119714A (ko) | 리오티로닌의 제어 방출 의약 조성물 및 그의 제조 및 사용방법 | |
| KR102512518B1 (ko) | 페마피브레이트를 함유하는 의약 | |
| CN118284422A (zh) | NF-κB介导的疾病的治疗 | |
| CN119072310A (zh) | 替洛利生用于治疗严重疲劳的新用途 | |
| JP2021526524A (ja) | ヒスタミン−３受容体インバースアゴニストを用いる処置の方法 | |
| WO2021161983A1 (en) | Novel medicament for treating inflammatory disease |